Lakewood Capital Management, LP Charles River Laboratories International, Inc. Transaction History
Lakewood Capital Management, LP
- $1.22 Billion
- Q1 2024
A detailed history of Lakewood Capital Management, LP transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Lakewood Capital Management, LP holds 112,740 shares of CRL stock, worth $22.8 Million. This represents 2.51% of its overall portfolio holdings.
Number of Shares
112,740
Previous 117,740
4.25%
Holding current value
$22.8 Million
Previous $27.8 Million
9.75%
% of portfolio
2.51%
Previous 2.36%
Shares
12 transactions
Others Institutions Holding CRL
# of Institutions
728Shares Held
51.3MCall Options Held
183KPut Options Held
346K-
Vanguard Group Inc Valley Forge, PA6.05MShares$1.22 Billion0.03% of portfolio
-
Black Rock Inc. New York, NY5.17MShares$1.05 Billion0.03% of portfolio
-
State Street Corp Boston, MA2.09MShares$424 Million0.03% of portfolio
-
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA1.88MShares$380 Million1.21% of portfolio
-
Clearbridge Investments, LLC New York, NY1.51MShares$306 Million0.34% of portfolio
About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Ticker CRL
- Exchange NYSE
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 50,863,300
- Market Cap $10.3B
- Description
- Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...